Publication Information

{'id': 'https://openalex.org/W2029788312', 'doi': 'https://doi.org/10.1111/bjh.13238', 'title': 'Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma', 'display_name': 'Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma', 'publication_year': 2014, 'publication_date': '2014-11-21', 'ids': {'openalex': 'https://openalex.org/W2029788312', 'doi': 'https://doi.org/10.1111/bjh.13238', 'mag': '2029788312', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/25413901'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13238', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13238', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13238', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5103423966', 'display_name': 'S. Y. Ong', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Shin‐Yeu Ong', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013054065', 'display_name': 'Hong Yen Ng', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Hong Yen Ng', 'raw_affiliation_strings': ['Department of Pharmacy Singapore General Hospital Singapore Singapore'], 'affiliations': [{'raw_affiliation_string': 'Department of Pharmacy Singapore General Hospital Singapore Singapore', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066518851', 'display_name': 'Shilpa Surendran', 'orcid': 'https://orcid.org/0000-0001-9534-2166'}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Shilpa Surendran', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090626293', 'display_name': 'Yeh Ching Linn', 'orcid': 'https://orcid.org/0000-0001-8098-2590'}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Yeh Ching Linn', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077467601', 'display_name': 'YunXin Chen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'YunXin Chen', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028165330', 'display_name': 'Yeow Tee Goh', 'orcid': 'https://orcid.org/0000-0002-7069-0997'}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Yeow Tee Goh', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042375742', 'display_name': 'Colin Phipps Diong', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Colin Diong', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5104230673', 'display_name': 'Sathish Gopalakrishnan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2251586001', 'display_name': 'Singapore General Hospital', 'ror': 'https://ror.org/036j6sg82', 'country_code': 'SG', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2251586001']}], 'countries': ['SG'], 'is_corresponding': False, 'raw_author_name': 'Sathish Kumar Gopalakrishnan', 'raw_affiliation_strings': [' Department of Haematology, Singapore General Hospital, Singapore, Singapore.'], 'affiliations': [{'raw_affiliation_string': ' Department of Haematology, Singapore General Hospital, Singapore, Singapore.', 'institution_ids': ['https://openalex.org/I2251586001']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 11, 'citation_normalized_percentile': {'value': 0.783754, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '169', 'issue': '5', 'first_page': '754', 'last_page': '756'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9951, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9866, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.855903}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.8128704}, {'id': 'https://openalex.org/C2780401358', 'wikidata': 'https://www.wikidata.org/wiki/Q422252', 'display_name': 'Dexamethasone', 'level': 2, 'score': 0.8015232}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7997277}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.7305428}, {'id': 'https://openalex.org/C2779609412', 'wikidata': 'https://www.wikidata.org/wiki/Q203174', 'display_name': 'Thalidomide', 'level': 3, 'score': 0.65107477}, {'id': 'https://openalex.org/C2776063141', 'wikidata': 'https://www.wikidata.org/wiki/Q425681', 'display_name': 'Lenalidomide', 'level': 3, 'score': 0.6354275}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.52576405}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.49763897}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4814574}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42220333}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.33045918}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13238', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13238', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/25413901', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13238', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13238', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.76, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 9, 'referenced_works': ['https://openalex.org/W1969648097', 'https://openalex.org/W1980168719', 'https://openalex.org/W1985947990', 'https://openalex.org/W2013370486', 'https://openalex.org/W2015003025', 'https://openalex.org/W2044436186', 'https://openalex.org/W2055338149', 'https://openalex.org/W2169183166', 'https://openalex.org/W2980391667'], 'related_works': ['https://openalex.org/W3047575701', 'https://openalex.org/W3042537788', 'https://openalex.org/W2462844398', 'https://openalex.org/W2362389383', 'https://openalex.org/W2118465399', 'https://openalex.org/W2058009067', 'https://openalex.org/W2041042375', 'https://openalex.org/W2022036807', 'https://openalex.org/W1980068016', 'https://openalex.org/W1974135782'], 'abstract_inverted_index': {'Regimens': [0], 'that': [1, 84, 113, 197, 635, 690], 'combine': [2], 'bortezomib': [3, 83, 397, 638, 709], 'and': [4, 17, 46, 77, 130, 159, 204, 252, 299, 312, 323, 331, 354, 395, 420, 453, 458, 472, 500, 544, 606, 627, 683, 730, 744, 784, 794, 802], 'steroids': [5], 'with': [6, 102, 116, 154, 211, 246, 265, 329, 392, 403, 443, 491, 566, 575, 586, 735, 771], 'thalidomide,': [7], 'lenalidomide': [8], 'or': [9, 123, 136, 359, 429, 447, 485], 'cyclophosphamide': [10, 75, 163, 188, 216, 234, 251, 302, 394, 512, 695, 740], 'have': [11], 'resulted': [12], 'in': [13, 23, 87, 147, 231, 239, 262, 412, 493, 522, 529, 548, 563, 598, 632, 639, 667, 715], 'high': [14, 400, 417, 433, 477, 540, 728], 'response': [15, 125, 134, 191, 339, 401, 438, 468, 503], 'rates': [16, 207, 402, 504, 594, 621, 656, 699], 'are': [18, 85, 505, 696, 703, 761], 'now': [19], 'considered': [20], 'standard': [21, 576, 773], 'treatments': [22], 'newly': [24, 266], 'diagnosed,': [25], 'transplant-eligible': [26, 260], 'multiple': [27, 98, 269], 'myeloma': [28, 270], '(Reeder': [29, 581, 748], 'et': [30, 34, 38, 108, 177, 218, 383, 515, 535, 582, 647, 651, 749, 754], 'al,': [31, 35, 39, 178, 219, 384, 583, 648, 750, 755], '2009;': [32], 'Cavo': [33], '2010;': [36], 'Richardson': [37], '2010).': [40], 'The': [41, 333, 349, 463, 705], 'comparison': [42], 'between': [43], 'bortezomib-thalidomide-dexamethasone': [44], '(VTD)': [45], 'bortezomib-cyclophosphamide-dexamethasone': [47], '(VCD)': [48], 'as': [49, 92], 'induction': [50], 'therapy': [51, 345, 666], 'is': [52, 616, 676], 'important': [53], 'given': [54, 286], 'the': [55, 74, 78, 88, 104, 148, 174, 194, 224, 232, 337, 341, 364, 367, 375, 387, 410, 413, 432, 436, 474, 587, 592, 619, 633, 724, 727, 765, 768, 806, 811], 'significantly': [56, 119], 'lower': [57, 166, 568], 'drug': [58], 'costs': [59], 'of': [60, 73, 80, 82, 90, 157, 187, 215, 228, 250, 281, 284, 291, 343, 351, 366, 390, 409, 476, 487, 526, 542, 554, 589, 595, 622, 657, 694, 707, 720, 732, 739, 767], 'these': [61], 'regimens': [62, 153, 160], 'compared': [63, 141, 574, 663], 'to': [64, 69, 142, 165, 189, 347, 374, 399, 466, 507, 618, 664, 701, 763], 'bortezomib-lenalidomide-dexamethasone': [65], '(VRD).': [66], 'We': [67, 100, 256], 'aim': [68], 'highlight': [70], 'certain': [71], 'aspects': [72], 'dosing': [76, 156, 186, 249], 'route': [79], 'administration': [81], 'crucial': [86], 'success': [89], 'VCD': [91, 149, 244, 275, 344, 391, 528, 555, 558, 665, 733, 769], 'an': [93, 212, 519, 736], 'upfront': [94, 527], 'treatment': [95, 245, 276], 'regime': [96], 'for': [97, 183, 357, 497], 'myeloma.': [99], 'read': [101], 'interest': [103], 'meta-analysis': [105, 669], 'by': [106, 173, 223, 685], 'Leiba': [107, 650], 'al': [109, 516, 536, 652], '(2014),': [110], 'which': [111], 'concluded': [112], 'patients': [114, 230, 261, 326, 411, 549, 578], 'treated': [115], 'VTD': [117, 662], 'had': [118, 327, 416], 'higher': [120, 185, 233, 248, 511, 655, 692], 'near': [121], 'complete': [122, 124], '(nCR/CR)': [126], '(34%': [127], 'vs.': [128, 139, 202, 209, 671], '6%)': [129], 'very': [131, 717], 'good': [132], 'partial': [133], '(VGPR)': [135], 'better': [137, 199], '(62%': [138], '27%),': [140], 'VCD-treated': [143], 'patients.': [144], 'Studies': [145], 'included': [146], 'arm': [150, 634], 'used': [151], 'heterogeneous': [152], 'different': [155], 'cyclophosphamide,': [158], 'using': [161, 510], 'less': [162, 561], 'led': [164, 398], 'CR': [167, 448], 'rates,': [168], 'a': [169, 184, 247, 289, 404, 523, 539, 567, 640, 711, 716], 'point': [170], 'also': [171], 'noted': [172], 'authors': [175, 809], '(Leiba': [176], '2014).': [179, 584], 'In': [180, 236, 673], 'particular,': [181], 'support': [182], 'deepen': [190], 'comes': [192], 'from': [193, 678, 741], 'EVOLUTION': [195], 'trial': [196, 645], 'achieved': [198], 'nCR/CR': [200], '(12%': [201], '3%)': [203], '≥': [205, 546, 608, 629], 'VGPR': [206, 547], '(41%': [208], '13%)': [210], 'additional': [213, 393], 'dose': [214, 355, 738], '(Kumar': [217], '2012),': [220], 'albeit': [221], 'limited': [222], 'small': [225], 'sample': [226], 'size': [227], '17': [229], 'arm.': [235], 'our': [237, 263, 599, 686, 742], 'institution': [238], 'Singapore,': [240], 'we': [241], 'routinely': [242], 'use': [243, 588, 706], 'subcutaneously': [253, 287], 'administered': [254], 'bortezomib.': [255], 'retrospectively': [257], 'analysed': [258, 787], '46': [259], 'hospital': [264], 'diagnosed': [267], 'symptomatic': [268], 'who': [271, 550], 'were': [272, 362, 371, 422, 489], 'initiated': [273], 'on': [274, 294, 306, 318, 710], '(Table': [277, 461, 613], '1).': [278, 462], 'Treatment': [279], 'consisted': [280], '28-d': [282], 'cycles': [283, 352, 553], 'bortezomib,': [285, 591], 'at': [288, 303, 315, 340, 363], 'concentration': [290], '1·3': [292], 'mg/m2': [293], 'days': [295, 307, 319], '1,': [296, 308, 320], '8,': [297, 309, 321], '15': [298, 322], '22,': [300, 311], 'oral': [301, 313], '500': [304], 'mg': [305, 317], '15and': [310], 'dexamethasone': [314], '40': [316], '22.': [324], 'All': [325, 808], 'prophylaxis': [328], 'co-trimoxazole': [330], 'acyclovir.': [332], 'primary': [334], 'endpoint': [335], 'was': [336, 441, 456, 469, 602], 'best': [338, 467], 'end': [342], 'prior': [346, 746], 'transplant.': [348], 'number': [350], 'used,': [353, 697], 'modification': [356], 'haematological': [358], 'non-haematological': [360], 'toxicities': [361], 'discretion': [365], 'treating': [368], 'physician.': [369], 'Responses': [370], 'assessed': [372], 'according': [373], 'International': [376, 423], 'Myeloma': [377], 'Working': [378], 'Group': [379], '(IMWG)': [380], 'criteria': [381], '(Durie': [382], '2006).': [385], 'Using': [386], 'intensified': [388, 737], 'regimen': [389, 734, 770], 'subcutaneous': [396, 590, 637, 708], 'favourable': [405], 'side-effect': [406], 'profile.': [407], '39%': [408], 'study': [414, 525, 600, 689], 'population': [415], 'risk': [418, 434, 478, 577], 'cytogenetics': [419], '83%': [421], 'Scoring': [424], 'System': [425], '(ISS)': [426], 'stage': [427, 481, 483], 'II': [428, 681], 'III.': [430], 'Despite': [431], 'profile,': [435], 'overall': [437, 451, 593, 605, 626], 'rate': [439], '(ORR)': [440], '91%,': [442], '46%': [444], 'achieving': [445], 'nCR': [446], 'pre-transplant.': [449, 556], 'One-year': [450], 'survival': [452, 455, 571], 'progression-free': [454, 570], '94%': [457], '87%,': [459], 'respectively': [460], 'mean': [464], 'time': [465], '5·3': [470], 'months,': [471], 'neither': [473], 'presence': [475, 486], 'cytogenetics,': [479], 'advanced': [480], '(ISS': [482], 'III)': [484, 631], 'comorbidities': [488], 'associated': [490], 'non-response': [492], 'multivariate': [494], 'models': [495], 'controlling': [496], 'age,': [498], 'race': [499], 'gender.': [501], 'These': [502], 'equivalent': [506], 'other': [508, 745, 772], 'studies': [509, 682, 747], 'dosing.': [513], 'Kumar': [514, 753, 786, 804], '(2013)': [517], 'reported': [518, 538, 620, 654], '89%': [520], 'ORR': [521, 541], 'retrospective': [524, 687], 'two': [530, 679], 'US': [531], 'centres,': [532], 'while': [533], 'Reeder': [534], '(2014)': [537, 653], '93%': [543], '67%': [545], 'completed': [551], 'four': [552], 'However,': [557], 'may': [559], 'be': [560], 'effective': [562], 'high-risk': [564], 'patients,': [565], '5-year': [569], '(27·6': [572], 'months)': [573, 580], '(55': [579], 'Furthermore,': [585], 'peripheral': [596, 611, 623, 721], 'neuropathy': [597, 624], 'group': [601], 'low': [603, 718], '(21%': [604], '6·5%': [607], 'grade': [609, 630, 658], 'III': [610, 642], 'neuropathy)': [612], '2).': [614], 'This': [615], 'comparable': [617], '(35%': [625], '5%': [628], 'received': [636], 'phase': [641, 680], 'randomized': [643, 758], 'control': [644], '(Moreau': [646], '2011).': [649], '3–4': [659], 'neurotoxicity': [660], 'during': [661], 'their': [668], '(11%': [670], '6%).': [672], 'summary,': [674], 'it': [675], 'evident': [677], 'supported': [684], 'cohort': [688], 'when': [691], 'doses': [693], 'CR/nCR': [698], 'close': [700], '40%': [702], 'seen.': [704], 'weekly': [712], 'schedule': [713], 'results': [714], 'incidence': [719], 'neuropathy.': [722], 'Given': [723], 'data': [725], 'demonstrating': [726], 'efficacy': [729, 766], 'tolerability': [731], 'centre': [743], '2009,': [751], '2014;': [752], '2013),': [756], 'future': [757], 'controlled': [759], 'trials': [760], 'warranted': [762], 'compare': [764], 'combination': [774], 'therapies.': [775], 'Shin': [776, 799], 'Yeu': [777, 800], 'Ong,': [778], 'Hong': [779], 'Yen': [780], 'Ng,': [781], 'Shilpa': [782], 'Surendran': [783], 'Sathish': [785, 803], 'data.': [788, 798], 'Yeow': [789], 'Tee': [790], 'Goh,': [791], 'YunXin': [792], 'Chen': [793], 'Colin': [795], 'Diong': [796], 'acquired': [797], 'Ong': [801], 'wrote': [805], 'manuscript.': [807], 'approved': [810], 'final': [812], 'paper.': [813]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2029788312', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 2}], 'updated_date': '2024-12-09T08:15:35.170834', 'created_date': '2016-06-24'}